The results demonstrated that the expression levels of KLRG1 and ST2 in ILC2s derived from tumor tissue were comparatively lower when compared to ILC2s derived from splenic tissue (Fig. 2C–F). This evidence concerns the gene KLRG1 and neoplasm.